Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Study Status and Recruitment Status were updated to Completed, replacing the previous Active, not recruiting status.SummaryDifference0.2%

- Check34 days agoChange DetectedThe history adds Revision: v3.4.2 and removes a government-funding/operating-status notice and Revision: v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedNotice about a lapse in government funding and an updated site revision (v3.4.1) appear in the history; both are administrative updates and do not affect trial data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a glossary toggle, green highlights for additions and red highlights for deletions, and an updated revision badge (v3.4.0), with No FEAR Act data text removed and older revision text (v3.3.4) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the prior revision v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.